EMA Defers U.S. GMP Inspections Pending November Activation of Mutual Agreement

International Pharmaceutical Regulatory Monitor
A A
The European Medicines Agency is putting off plans for GMP inspections in the U.S. when possible, an EMA spokesperson confirmed, in anticipation of the November launch of a mutual agreement between the EU and U.S.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor